Literature DB >> 33399094

Arbitrary-order sliding mode-based robust control algorithm for the developing artificial pancreas mechanism.

Waqar Alam1, Qudrat Khan2, Raja Ali Riaz1, Rini Akmeliawati3.   

Abstract

In Diabetes Mellitus, the pancreas remains incapable of insulin administration that leads to hyperglycaemia, an escalated glycaemic concentration, which may stimulate many complications. To circumvent this situation, a closed-loop control strategy is much needed for the exogenous insulin infusion in diabetic patients. This closed-loop structure is often termed as an artificial pancreas that is generally established by the employment of different feedback control strategies. In this work, the authors have proposed an arbitrary-order sliding mode control approach for development of the said mechanism. The term, arbitrary, is exercised in the sense of its applicability to any n-order controllable canonical system. The proposed control algorithm affirms the finite-time effective stabilisation of the glucose-insulin regulatory system, at the desired level, with the alleviation of sharp fluctuations. The novelty of this work lies in the sliding manifold that incorporates indirect non-linear terms. In addition, the necessary discontinuous terms are filtered-out once before its employment to the plant, i.e. diabetic patient. The robustness, in the presence of external disturbances, i.e. meal intake is confirmed via rigorous mathematical stability analysis. In addition, the effectiveness of the proposed control strategy is ascertained by comparing the results with the standard literature.

Entities:  

Mesh:

Year:  2020        PMID: 33399094      PMCID: PMC8687268          DOI: 10.1049/iet-syb.2018.5075

Source DB:  PubMed          Journal:  IET Syst Biol        ISSN: 1751-8849            Impact factor:   1.615


  15 in total

1.  Expert PID control system for blood glucose control in critically ill patients.

Authors:  Frederick Chee; Tyrone L Fernando; Andrey V Savkin; Vernon van Heeden
Journal:  IEEE Trans Inf Technol Biomed       Date:  2003-12

Review 2.  Minimal model: perspective from 2005.

Authors:  Richard N Bergman
Journal:  Horm Res       Date:  2006-01-20

3.  A minimal model for glycemia control in critically ill patients.

Authors:  Tom Van Herpe; Bert Pluymers; Marcelo Espinoza; Greet Van den Berghe; Bart De Moor
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2006

4.  A semiclosed-loop algorithm for the control of blood glucose levels in diabetics.

Authors:  M E Fisher
Journal:  IEEE Trans Biomed Eng       Date:  1991-01       Impact factor: 4.538

5.  Optimal H infinity insulin injection control for blood glucose regulation in diabetic patients.

Authors:  Frederick Chee; Andrey V Savkin; Tyrone L Fernando; Saeid Nahavandi
Journal:  IEEE Trans Biomed Eng       Date:  2005-10       Impact factor: 4.538

6.  Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas.

Authors:  Stuart A Weinzimer; Garry M Steil; Karena L Swan; Jim Dziura; Natalie Kurtz; William V Tamborlane
Journal:  Diabetes Care       Date:  2008-02-05       Impact factor: 19.112

7.  Blood glucose concentration control for type 1 diabetic patients: a non-linear suboptimal approach.

Authors:  Yazdan Batmani
Journal:  IET Syst Biol       Date:  2017-08       Impact factor: 1.615

8.  Post-prandial hyperglycemia.

Authors:  Santosh Kumar Singh
Journal:  Indian J Endocrinol Metab       Date:  2012-12

9.  Regulation of Blood Glucose Concentration in Type 1 Diabetics Using Single Order Sliding Mode Control Combined with Fuzzy On-line Tunable Gain, a Simulation Study.

Authors:  Soudabeh Taghian Dinani; Maryam Zekri; Marzieh Kamali
Journal:  J Med Signals Sens       Date:  2015 Jul-Sep

10.  Robust observer based control for plasma glucose regulation in type 1 diabetes patient using attractive ellipsoid method.

Authors:  Anirudh Nath; Rajeeb Dey
Journal:  IET Syst Biol       Date:  2019-04       Impact factor: 1.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.